IL142858A0 - Treatment of tumors by administration of growth hormone releasing compounds and their antagonists - Google Patents

Treatment of tumors by administration of growth hormone releasing compounds and their antagonists

Info

Publication number
IL142858A0
IL142858A0 IL14285899A IL14285899A IL142858A0 IL 142858 A0 IL142858 A0 IL 142858A0 IL 14285899 A IL14285899 A IL 14285899A IL 14285899 A IL14285899 A IL 14285899A IL 142858 A0 IL142858 A0 IL 142858A0
Authority
IL
Israel
Prior art keywords
antagonists
tumors
administration
treatment
growth hormone
Prior art date
Application number
IL14285899A
Other languages
English (en)
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of IL142858A0 publication Critical patent/IL142858A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL14285899A 1998-11-16 1999-11-11 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists IL142858A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/192,406 US6124263A (en) 1998-11-16 1998-11-16 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
PCT/EP1999/008662 WO2000029011A1 (en) 1998-11-16 1999-11-11 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists

Publications (1)

Publication Number Publication Date
IL142858A0 true IL142858A0 (en) 2002-03-10

Family

ID=22709509

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14285899A IL142858A0 (en) 1998-11-16 1999-11-11 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists

Country Status (30)

Country Link
US (1) US6124263A (no)
EP (1) EP1131083B1 (no)
JP (1) JP2002529512A (no)
KR (1) KR100704138B1 (no)
CN (3) CN100368014C (no)
AR (1) AR021286A1 (no)
AT (1) ATE258062T1 (no)
BG (1) BG105572A (no)
BR (1) BR9915390A (no)
CA (1) CA2350914A1 (no)
CO (1) CO5140111A1 (no)
CZ (1) CZ20011577A3 (no)
DE (1) DE69914365T2 (no)
DK (1) DK1131083T3 (no)
ES (1) ES2212650T3 (no)
HK (1) HK1040934A1 (no)
HU (1) HUP0104374A3 (no)
IL (1) IL142858A0 (no)
MX (1) MXPA01004689A (no)
NO (1) NO20012367L (no)
NZ (1) NZ511280A (no)
PL (1) PL347659A1 (no)
PT (1) PT1131083E (no)
RU (1) RU2240133C2 (no)
SK (1) SK6352001A3 (no)
TR (1) TR200101350T2 (no)
TW (2) TWI237565B (no)
UA (1) UA73100C2 (no)
WO (1) WO2000029011A1 (no)
ZA (1) ZA200103182B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211156B1 (en) * 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
CU23157A1 (es) * 2001-01-03 2006-07-18 Ct Ingenieria Genetica Biotech COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL
DE10112882A1 (de) * 2001-03-15 2002-09-19 Max Delbrueck Centrum Verwendung von Tryptophan-Derivaten zur spezifischen zytostatischen Behandlung von Serotonin-produzierenden Tumoren
WO2002090387A1 (en) * 2001-05-10 2002-11-14 Queensland University Of Technology Reproductive cancer diagnosis and therapy
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
TWI331922B (en) 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US20050164952A1 (en) * 2004-01-23 2005-07-28 Vital Pharmaceuticals, Inc. Delivery system for growth hormone releasing peptides
WO2007127457A2 (en) * 2006-04-28 2007-11-08 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
RU2459831C2 (ru) 2006-09-27 2012-08-27 Ипсен Фарма С.А.С. Аналоги грелина с замещением на n-конце
KR20090112720A (ko) 2007-02-13 2009-10-28 헬신 세라퓨틱스 (유.에스.) 인크. 성장 호르몬 분비촉진제를 이용한 세포 증식 질환의 치료방법
US8841257B2 (en) * 2009-04-10 2014-09-23 Board Of Regents, The University Of Texas System Inhibitors of STAT3 and uses thereof
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
IT1399610B1 (it) * 2010-01-28 2013-04-26 Univ Milano Bicocca Uso di agonisti e antagonisti dei recettori per i growth hormone secretagogues per la prevenzione e il trattamento di convulsioni ed epilessia
WO2020163833A2 (en) 2019-02-08 2020-08-13 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof
WO2021011874A1 (en) * 2019-07-18 2021-01-21 University Of Miami Ghrh antagonists for use in a method of treating sarcoidosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU217636B (hu) * 1989-04-26 2000-03-28 Administrators Of The Tulane Educational Fund Szomatosztatin analógok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
IT1240643B (it) * 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
US5385682A (en) * 1990-05-15 1995-01-31 Exxon Research & Engineering Co. Grease composition
DE69434181T2 (de) * 1993-08-09 2005-12-01 Société de Conseils de Recherches et d'Applications Scientifiques S.A.S. Therapeutische Peptidderivate
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
US5807985A (en) * 1996-06-11 1998-09-15 Deghenghi; Romano Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
US6063796A (en) * 1997-04-04 2000-05-16 Merck & Co., Inc. Somatostatin agonists

Also Published As

Publication number Publication date
CN1594358A (zh) 2005-03-16
SK6352001A3 (en) 2002-09-10
DK1131083T3 (da) 2004-04-26
TWI263642B (en) 2006-10-11
UA73100C2 (en) 2005-06-15
DE69914365T2 (de) 2004-11-04
CN1277840C (zh) 2006-10-04
PL347659A1 (en) 2002-04-22
ZA200103182B (en) 2001-09-07
KR100704138B1 (ko) 2007-04-09
ES2212650T3 (es) 2004-07-16
NO20012367D0 (no) 2001-05-14
NZ511280A (en) 2002-10-25
TR200101350T2 (tr) 2001-11-21
KR20010089459A (ko) 2001-10-06
TWI237565B (en) 2005-08-11
EP1131083A1 (en) 2001-09-12
JP2002529512A (ja) 2002-09-10
CN1895660A (zh) 2007-01-17
CA2350914A1 (en) 2000-05-25
BR9915390A (pt) 2001-08-07
MXPA01004689A (es) 2002-09-18
CN100368014C (zh) 2008-02-13
HUP0104374A2 (hu) 2002-04-29
HUP0104374A3 (en) 2003-03-28
CN1326353A (zh) 2001-12-12
EP1131083B1 (en) 2004-01-21
CZ20011577A3 (cs) 2002-07-17
CN1200726C (zh) 2005-05-11
HK1040934A1 (zh) 2002-06-28
TW200530270A (en) 2005-09-16
WO2000029011A1 (en) 2000-05-25
RU2240133C2 (ru) 2004-11-20
US6124263A (en) 2000-09-26
CO5140111A1 (es) 2002-03-22
AR021286A1 (es) 2002-07-03
PT1131083E (pt) 2004-06-30
ATE258062T1 (de) 2004-02-15
BG105572A (en) 2002-01-31
DE69914365D1 (de) 2004-02-26
NO20012367L (no) 2001-07-09

Similar Documents

Publication Publication Date Title
PL347659A1 (en) Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
PL344831A1 (en) Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
HUP0201480A2 (en) Treatment of refractory human tumors with epidermal growth factor receptor antagonists
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
IL137445A0 (en) Pharmaceutically active compounds and methods of use thereof
PL327634A1 (en) Growth hormone secretion stimulating compounds
HUP9900870A3 (en) Composition for sustained release of human growth hormone
PL338883A1 (en) Growth hormone secretion stimulating compounds
HUP0200275A3 (en) Seed treatment composition and preparation thereof
EP1117357A4 (en) METHODS AND DEVICES FOR IMPROVING THE ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS
HK1042825A1 (zh) 治療氣道疾病的化合物和方法以及氣道藥物的給藥方法
IL133053A0 (en) Local delivery of long lasting therapeutic agents
DE69827357D1 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
EP1115396A4 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS, AND METHODS OF USE THEREOF
EP1054900A4 (en) THERAPEUTIC USE OF THE KERATINOCTENT GROWTH FACTOR-2
EP1154997A4 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
GB9602414D0 (en) Camphor compounds promote release of growth hormone
HUP0102460A3 (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising thereof and their use
HUP0401589A3 (en) New peptides - analogs of human growth hormone-releasing hormone
EE200000193A (et) Kasvuhormoonide sekreteerimist stimuleerivate ühendite valmistamise protsess
GB9906808D0 (en) Formulation for treatment of pain
GB9904252D0 (en) Composition for the treatment of pain
HK1040610A1 (zh) 用於改善藥理活性化合物給藥的方法和裝置